tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market

Plus Therapeutics (PSTV) Financial Statements

Compare
1,701 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently $53.44M. The company's EPS TTM is $; its P/E ratio is ―; Plus Therapeutics is scheduled to report earnings on February 19, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 5.82M$ 4.91M$ 224.00K$ 0.00$ 303.00K
Gross Profit$ 4.97M$ -4.78M$ -488.00K$ -66.00K$ -2.40M
Operating Income$ -14.70M$ -13.32M$ -19.71M$ -12.49M$ -9.58M
EBITDA$ -8.40M$ -12.69M$ -18.85M$ -12.05M$ -8.44M
Net Income$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Balance Sheet
Cash & Short-Term Investments$ 3.61M$ 8.55M$ 18.12M$ 18.40M$ 8.35M
Total Assets$ 6.63M$ 11.39M$ 23.87M$ 21.98M$ 12.11M
Total Debt$ 3.37M$ 4.18M$ 5.75M$ 6.99M$ 7.00M
Net Debt$ 3.29M$ -4.37M$ -12.37M$ -11.41M$ -1.35M
Total Liabilities$ 15.58M$ 12.74M$ 17.42M$ 11.14M$ 9.07M
Stockholders' Equity$ -8.95M$ -1.35M$ 6.45M$ 10.84M$ 3.03M
Cash Flow
Free Cash Flow$ -10.70M$ -13.01M$ -13.73M$ -10.42M$ -8.93M
Operating Cash Flow$ -10.55M$ -12.85M$ -12.97M$ -10.28M$ -8.43M
Investing Cash Flow$ -4.11M$ -160.00K$ -759.00K$ -82.00K$ -493.00K
Financing Cash Flow$ 6.19M$ 3.44M$ 13.45M$ 20.42M$ -319.00K
Currency in USD

Plus Therapeutics Earnings and Revenue History

Plus Therapeutics Debt to Assets

Plus Therapeutics Cash Flow

Plus Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.